Gastric cancer
Conditions
Interventions
Oral nutritional supplements for patients after gastrectomy
Sponsors
Kobe University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Gastric cancer patients who are diagnosed to be clinical Stage 1,2 and 3 according to the Japanese classification for gastric cancer and who are going to undergo distal gastrectomy or total gastrectomy (2) ECOG-PS 0 to 2 (3) Patients who are able to oral intake before gastrectomy (4) A patient whose written informed consent has been obtained
Exclusion criteria
Exclusion criteria: (1) Patients with allergies to oral nutritional supplements (2) Patients who are judged unsuitable for the study by the principal investigator or sub-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body weight loss rate at 3 months after gastrectomy | — |
Secondary
| Measure | Time frame |
|---|---|
| The adherence of ENORAS oral intake dose (continuous internal use completion rate), Total calorie intake at the 3 months after surgery (estimate from images or records of meal after gastrectomy), ECOG-PS, Nutritional index from blood test (TP, ALB, TLC), Bioelectrical impedance analysis, Visceral fat area and Skeletal muscle index from CT images | — |
Countries
Japan
Contacts
Public ContactHitoshi Harada
Graduate School of Medicine, Kobe University Division of Gastrointestinal Surgery, Department of Surgery
Outcome results
None listed